Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis bets on a slumping Aveo in a $326M cancer deal
Novartis bets on a slumping Aveo in a $326M cancer deal
Novartis bets on a slumping Aveo in a $326M cancer deal
Submitted by
admin
on August 17, 2015 - 10:13am
Source:
Fierce Biotech
News Tags:
Novaris
Aveo Oncology
AV-380
Headline:
Novartis bets on a slumping Aveo in a $326M cancer deal
Do Not Allow Advertisers to Use My Personal information
